Stay updated on Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Sign up to get notified when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.

Latest updates to the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 on the page.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed; this appears to be an administrative update with no visible impact on the study content or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a glossary display, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and revision label v3.4.0; removed Last Update Submitted that met QC Criteria, No FEAR Act data, and revision label v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page shows a minor revision update (Revision: v3.3.4) replacing the previous version v3.3.3 without affecting the core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedNew study locations were added across multiple countries (US, Argentina, Australia, Brazil, Canada, Denmark, France, Germany, Italy, Spain, Japan, China, etc.), expanding geographic coverage for the trial. Concurrently, several location entries were removed and the revision updated to v3.3.3.SummaryDifference0.9%

- Check92 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision tag from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.